Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide-Reference-Cited by-同舟云学术

Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide

Published:2023-08 Issue:8 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Lim I. Vern¹^ORCID,Yurttaş Nurgül Özgür²,Ayer Mesut²,Poturoğlu Şule³,Kınacı Erdem¹,Özden İlgin¹^ORCID

Affiliation:

1. Department of General Surgery, Liver Transplantation & Hepatopancreatobiliary Surgery Unit Başakşehir Çam & Sakura City Hospital Istanbul Turkey

2. Department of Internal Medicine, Division of Hematology Başakşehir Çam & Sakura City Hospital Istanbul Turkey

3. Department of Internal Medicine, Division of Gastroenterology Başakşehir Çam & Sakura City Hospital Istanbul Turkey

Abstract

Key Clinical MessageAt 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 109/L). Covid resolution and all “conventional” modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step‐by‐step judicious approach to post‐transplant neutropenia is vital.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7741

Reference24 articles.

1. Characteristics and outcomes of neutropenia after orthotopic liver transplantation

2. Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective Study

3. Leukopenia in Kidney Transplant Patients With the Association of Valganciclovir and Mycophenolate Mofetil

4. Hematologic toxicity of immunosuppressive treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-12-02